COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 1986: Articles 19851-19860  | Next

Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
Richard, A., Wisniak, A., Perez-Saez, J., Garrison-Desany, H., Petrovic, D., Piumatti, G., Baysson, H., Picazio, A., Pennacchio, F., De Ridder, D., Chappuis, F., Vuilleumier, N., Low, N., Hurst, S., Eckerle, I., Flahault, A., Kaiser, L., Azman, A. S., Guessous, I., Stringhini, S., SEROCOV-POP study group
10.1101/2020.12.16.20248180 — Posted: 2020-12-18
The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention
Thaker, J.
10.1101/2020.12.16.20248139 — Posted: 2020-12-18
Household bubbles and COVID-19 transmission: insights from percolation theory
Danon, L., Brooks-Pollock, E., Lacasa, L.
10.1101/2020.12.16.20248311 — Posted: 2020-12-18
Large-Scale Measurement of Aggregate Human Colocation Patterns for Epidemiological Modeling
Iyer, S., Karrer, B., Citron, D. T., Kooti, F., Maas, P., Wang, Z., Giraudy, E., Dow, P. A., Pompe, A.
10.1101/2020.12.16.20248272 — Posted: 2020-12-18
COVID19 is a seasonal climate-driven disease across both hemispheres
Fontal, A., Bouma, M. J., San Jose, A., Pascual, M., Rodo, X.
10.1101/2020.12.16.20248310 — Posted: 2020-12-18
Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China
Bushman, M., Worby, C. J., Chang, H.-H., Kraemer, M. U. G., Hanage, W. P.
10.1101/2020.12.16.20214106 — Posted: 2020-12-18
Clinical validation of a point-of-care antibody test for COVID-19
Patel, M., Lakhotia, Y., Shah, S., Suthar, N., Kola, S., Rangarajan, R.
10.1101/2020.12.16.20248303 — Posted: 2020-12-18
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
Morgenlander, W. R., Henson, S., Monaco, D., Chen, A., Littlefield, K., Bloch, E. M., Fujimura, E., Ruczinski, I., Crowley, A. R., Natarajan, H., Butler, S. E., Weiner, J. A., Li, M. Z., Bonny, T. S., Benner, S. E., Balagopal, A., Sullivan, D., Shoham, S., Quinn, T. C., Eshleman, S., Casadevall, A., Redd, A. D., Laeyendecker, O., Ackerman, M. E., Pekosz, A., Elledge, S. J., Robinson, M., Tobian, A. A. R., Larman, H. B.
10.1101/2020.12.16.20248294 — Posted: 2020-12-18
Impaired ICOS signaling between Tfh and B cells distinguishes hospitalized from ambulatory CoViD-19 patients
Hanson, A., Cohen, H., Wang, H., Shekhar, N., Shah, C., Dhaneshwar, A., Harvey, B. W., Murray, R., Harvey, C. J.
10.1101/2020.12.16.20248343 — Posted: 2020-12-18
Understanding the net benefit of antigen-based rapid diagnostic tests for COVID-19: An enhanced decision-curve analysis
Kendall, E. A., Arinaminpathy, N., Sacks, J. A., Manabe, Y. C., Dittrich, S., Schumacher, S. G., Dowdy, D. W.
10.1101/2020.12.16.20248357 — Posted: 2020-12-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).